Mayumi Thrombectomy System
MicroVention, Inc., d/b/a Terumo Neuro · Decision date Sep 3, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision for the Mayumi™ Thrombectomy System, submitted by MicroVention, Inc., d/b/a Terumo Neuro, on September 3, 2026, under 510(k) K254035. The device is classified as an embolectomy catheter under 21 CFR 870.5150, Class II, with product codes QEZ and KRA, in the cardiovascular specialty. SESE means the device was cleared for marketing, not approved through a PMA. The summary lists K213402 (Triever24, Triever20) as the predicate.
The Mayumi system is a single-use, sterile, non-pyrogenic aspiration catheter set offered in 20Fr and 24Fr configurations, packaged with a dilator and Y-connector; the Y-connector is an addition relative to the predicate. The stated indications cover non-surgical removal of emboli and thrombi from blood vessels and injection, infusion or aspiration of fluids, limited to the peripheral vasculature. The summary states the submission does not claim pulmonary embolism treatment or clot-in-transit treatment in the right atrium. Bench testing listed includes device compatibility, physical attributes, aspiration suction volume and shaft performance; clinical outcome data are not described in the provided excerpts.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 3, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254035
- Regulatory pathway
- 510(k) premarket notification
- Product code
- QEZ
- Decision code
- SESE
- Decision date
- Sep 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Aspiration Thrombectomy Catheter.
- Product code
- QEZ
- FDA device class
- 2
FDA decision timeline
K254035 received
Application receipt date recorded by FDA.
K254035 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QEZ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
FLOWRUNNER Aspiration SystemK262864 | Expanse Medical, Inc. | 510(k) clearance | Oct 26, 2026 | FDA |
| Inquis Medical | 510(k) clearance | Jul 27, 2026 | FDA | |
Aventus Thrombectomy SystemK262030 | Inquis Medical | 510(k) clearance | Jul 15, 2026 | FDA |
| Medtronic Interventional Vascular, Inc. | 510(k) clearance | Apr 23, 2026 | FDA | |
FLOWRUNNER Aspiration SystemK254208 | Expanse Medical, Inc. | 510(k) clearance | Mar 20, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
MicroVention, Inc., d/b/a Terumo Neuro
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Aliso Viejo, CA
Sources and methodology
- Original FDA record: K254035
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


